These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26203853)

  • 1. Hepatitis A: epidemiology in resource-poor countries.
    Aggarwal R; Goel A
    Curr Opin Infect Dis; 2015 Oct; 28(5):488-96. PubMed ID: 26203853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].
    Pan XJ; Feng YM; Zhuang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):862-6. PubMed ID: 22967346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH; Pan XJ; Wang XL
    Vaccine; 2008 Aug; 26(35):4608-16. PubMed ID: 18597903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and prevention of hepatitis A in travelers.
    Steffen R; Kane MA; Shapiro CN; Billo N; Schoellhorn KJ; van Damme P
    JAMA; 1994 Sep; 272(11):885-9. PubMed ID: 8078167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A vaccine should receive priority in National Immunization Schedule in India.
    Verma R; Khanna P
    Hum Vaccin Immunother; 2012 Aug; 8(8):1132-4. PubMed ID: 22854671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral hepatitis A: when a changing epidemiology implies a different prophylaxis].
    Martet G; Morillon M; Debonne JM; Louis FJ
    Sante; 1998; 8(2):113-7. PubMed ID: 9642731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
    Barkai G; Belmaker I; Givon-Lavi N; Dagan R
    Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina.
    Vizzotti C; Pippo T; Urueña A; Altuna J; Palópoli G; Hernández ML; Artola MF; Fernández H; Orellano P; Cañero-Velasco MC; Ciocca M; Ramonet M; Diosque M
    Vaccine; 2015 May; 33 Suppl 1():A227-32. PubMed ID: 25919166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP; Gregor JC; Marotta PJ
    Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
    Valenzuela MT; Jacobs RJ; Arteaga O; Navarrete MS; Meyerhoff AS; Innis BL
    Vaccine; 2005 Jul; 23(32):4110-9. PubMed ID: 15964479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
    Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B
    Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy.
    Vitral CL; Souto FJ; Gaspar AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():22-5. PubMed ID: 18837829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing incidence of hepatitis A in Korean adults.
    Kim YJ; Lee HS
    Intervirology; 2010; 53(1):10-4. PubMed ID: 20068335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries.
    Mathur P; Arora NK
    Indian J Med Res; 2008 Dec; 128(6):699-704. PubMed ID: 19246792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
    Hendrickx G; Van Herck K; Vorsters A; Wiersma S; Shapiro C; Andrus JK; Ropero AM; Shouval D; Ward W; Van Damme P
    J Viral Hepat; 2008 Oct; 15 Suppl 2():1-15. PubMed ID: 18837827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.